Vaccination in Pediatric Patients with Sickle-Cell Disease: Uptake Report and Mini-Review

Daniel Jarovsky1,2, Phillipe Romanzini Bastos2, Samantha Faria de Matos1

  • 1Pediatric Infectious Diseases, Santa Casa de São Paulo, São Paulo 01221-010, Brazil.

Insights

Pediatric patients with sickle-cell disease (SCD) in Brazil show concerningly low vaccination rates for crucial vaccines, especially those targeting encapsulated bacteria. This highlights a need to reassess prevention strategies for this vulnerable population.

Area of Science:

  • Pediatrics
  • Immunology
  • Hematology

Background:

  • Brazil has a high incidence of sickle-cell disease (SCD) in the Americas.
  • Vaccine-preventable infections pose severe risks to children with SCD.
  • Vaccination uptake in this pediatric group was previously unknown.

Purpose of the Study:

  • To evaluate the vaccination status of children under 18 with SCD in Brazil.
  • To compare vaccination coverage against national recommendations among different age groups.

Main Methods:

  • Retrospective analysis of vaccination cards from children with SCD.
  • Classification of vaccination status as 'Adequate', 'Delayed', or 'Missing'.
  • Comparison of vaccination rates across age cohorts.

Main Results:

  • Routine vaccine coverage exceeded 95% for primary series.
  • Significant delays and missed doses were observed for vaccines recommended for SCD patients, particularly against encapsulated bacteria (e.g., PPSV23, Hib, menC).
  • Influenza vaccination rate averaged 69.5%, higher in younger children.

Conclusions:

  • Children with SCD in Brazil exhibit alarming under-vaccination rates for recommended vaccines.
  • Current basic prevention strategies require reassessment for this specific pediatric population.
  • Targeted interventions are needed to improve vaccine adherence in children with SCD.
Abstract